Steven Biesmans

Steven Biesmans is a Principal (Director) at UCB Ventures, where they lead life science investment initiatives, managing the full investment cycle and aligning strategies with UCB Pharma's goals. With a Ph.D. in Neuroimmunology and over 12 years of preclinical drug discovery experience, they have developed innovative technology platforms and managed scientific programs across various research environments globally. Previously, Steven held roles at prominent institutions, including Sanford Burnham Prebys Medical Discovery Institute and Janssen, where they contributed to significant advancements in cellular models and drug discovery methodologies. Their extensive international network in the Life Sciences industry underscores their expertise and influence in the field.